Modulators of the urokinase-type plasminogen activation system for cancer

By Hildenbrand Ralf   Allgayer Heike   Marx Alexander   Stroebel Philipp  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 641-652

Informa Healthcare

Access to resources Recommend Favorite

New developments in the urokinase-type plasminogen activator system

By Rosenberg Steven  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 6, 2001-12 ,pp. : 711-722

Informa Healthcare

Access to resources Recommend Favorite

Preface The Urokinase-type Plasminogen Activator System in Cancer and other Pathological Conditions: Introduction and Perspective [Hot Topic: The Urokinase-type Plasminogen Activator System in Cancer (Executive Editor : S. Rosenberg)].

By  

Current Pharmaceutical Design, Vol. 9, Iss. 19, 2003-07 ,pp. : iv-iv

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin

By Dunbar S.D.   Ornstein D.L.   Zacharski L.R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. : 2085-2092

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutic targets in oncology: urokinase-type plasminogen activator system

By Magill C.   Katz B.A.   Mackman R.L.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 109-133

Informa Healthcare

Access to resources Recommend Favorite